|
MechanismPOLA1 inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date28 Oct 2005 |
|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date28 May 1996 |
100 Clinical Results associated with Sandoz Pharmaceuticals DD (Belarus)
0 Patents (Medical) associated with Sandoz Pharmaceuticals DD (Belarus)
100 Deals associated with Sandoz Pharmaceuticals DD (Belarus)
100 Translational Medicine associated with Sandoz Pharmaceuticals DD (Belarus)